PMPS reached out to some of the key voices in the pharma industry to get their predictions on the pharmaceutical trends of 2021, covering both current challenges and developments. Our chief commercial officer, Tony O’Sullivan, highlights the strain that the COVID-19 pandemic had on the active pharmaceutical ingredient (API) supply chain, and how drug manufacturers are working to make it more robust in future by using domestic suppliers.
